Abstract
Although most meningiomas are slow-growing tumours associated with favourable prognosis, they often present local recurrence after surgical treatment; by contrast, extracranial metastatic meningiomas are rare, occurring in less than 1% of the cases. Risk factors for distal spread remain largely unknown. We report three cases with lung or bone metastases from intracranial recurrent meningiomas. Loss of heterozygosity (LOH) analysis on 1p, 9p, 10q, 14q, and 22q was conducted in available primary, recurrent and metastatic lesions, showing the same LOH pattern in the distal metastases and in the intracranial meningioma. LOH at 1p, 14q and 9p, known to be associated with increased aggressiveness, were found. The results highlight the potential clinical relevance of integrating histopathological studies with molecular genetic analysis in the follow-up of patients with different types of meningiomas.
Similar content being viewed by others
References
Claus EB, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M, Black PM (2005) Epidemiology of intracranial meningioma. Neurosurgery 57:1088–1095 discussion 1088–1095
Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215–225 discussion 226–219
Enam SA, Abdulrauf S, Mehta B, Malik GM, Mahmood A (1996) Metastasis in meningioma. Acta Neurochir (Wien) 138:1172–1177 discussion 1177–1178
Delgado-Lopez PD, Martin-Velasco V, Castilla-Diez JM, Fernandez-Arconada O, Corrales-Garcia EM, Galacho-Harnero A, Rodriguez-Salazar A, Perez-Mies B (2006) Metastatic meningioma to the eleventh dorsal vertebral body: total en bloc spondylectomy. Case report and review of the literature. Neurocirugia (Astur) 17:240–249
Chamberlain MC, Glantz MJ (2005) Cerebrospinal fluid-disseminated meningioma. Cancer 103:1427–1430
Cai DX, Banerjee R, Scheithauer BW, Lohse CM, Kleinschmidt-Demasters BK, Perry A (2001) Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications. J Neuropathol Exp Neurol 60:628–636
Cerda-Nicolas M, Lopez-Gines C, Perez-Bacete M, Roldan P, Talamantes F, Barbera J (2003) Histologically benign metastatic meningioma: morphological and cytogenetic study. Case report. J Neurosurg 98:194–198
Lamszus K, Kluwe L, Matschke J, Meissner H, Laas R, Westphal M (1999) Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas. Cancer Genet Cytogen 110:103–110
Lee JY, Finkelstein S, Hamilton RL, Rekha R, King JT Jr., Omalu B (2004) Loss of heterozygosity analysis of benign, atypical, and anaplastic meningiomas. Neurosurgery 55:1163–1173
Mihaila D, Gutierrez JA, Rosenblum ML, Newsham IF, Bogler O, Rempel SA (2003) Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers. Clin Cancer Res 9:4435–4442
Perry A, Banerjee R, Lohse CM, Kleinschmidt-DeMasters BK, Scheithauer BW (2002) A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas. Brain Pathol 12:183–190
Kim YJ, Ketter R, Henn W, Zang KD, Steudel WI, Feiden W (2006) Histopathologic indicators of recurrence in meningiomas: correlation with clinical and genetic parameters. Virchows Arch 449:529–538
D’Aiuto M, Veronesi G, Pelosi G, Presicci PF, Ferraroli GM, Gasparri R, Spaggiari L (2005) Two-year survival after multiple bilateral lung metastasectomies for cranial meningioma. Ann Thorac Surg 80:1129–1130
Riemenschneider MJ, Perry A, Reifenberger G (2006) Histological classification and molecular genetics of meningiomas. Lancet Neurol 5:1045–1054
Al-Mefty O, Kadri PA, Pravdenkova S, Sawyer JR, Stangeby C, Husain M (2004) Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings. J Neurosurg 101:210–218
Schiffer D, Ghimenti C, Fiano V (2005) Absence of histological signs of tumor progression in recurrences of completely resected meningiomas. J Neurooncol 73:125–130
Weber RG, Bostrom J, Wolter M, Baudis M, Collins VP, Reifenberger G, Lichter P (1997) Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc Natl Acad Sci U S A 94:14719–14724
van Tilborg AA, Al Allak B, Velthuizen SC, de Vries A, Kros JM, Avezaat CJ, de Klein A, Beverloo HB, Zwarthoff EC (2005) Chromosomal instability in meningiomas. J Neuropathol Exp Neurol 64:312–322
Ruttledge MH, Xie YG, Han FY, Peyrard M, Collins VP, Nordenskjold M, Dumanski JP (1994) Deletions on chromosome 22 in sporadic meningioma. Genes Chromosomes Cancer 10:122–130
Bostrom J, Meyer-Puttlitz B, Wolter M, Blaschke B, Weber RG, Lichter P, Ichimura K, Collins VP, Reifenberger G (2001) Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Am J Pathol 159:661–669
Figueroa BE, Quint DJ, McKeever PE, Chandler WF (1999) Extracranial metastatic meningioma. Br J Radiol 72:513–516
Acknowledgements
This work was partially supported by grants from the “Associazione Italiana per la Ricerca contro il Cancro” and “Ministero della Salute” to GF.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gladin, C.R., Salsano, E., Menghi, F. et al. Loss of heterozygosity studies in extracranial metastatic meningiomas. J Neurooncol 85, 81–85 (2007). https://doi.org/10.1007/s11060-007-9386-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-007-9386-3